The aim of this study was to evaluate the analgesic efficacy (over a full 24-hour period) and safety profile of a new tramadol OAD formulation (Contramid ® controlled-release technology ...

Background Tramadol is a synthetic opioid not banned by WADA, but included in the Monitoring Program since 2012. The prevalence of use of tramadol in competition was approximately 5% in cycling. These ...

Objective: To compare the 24-hour sustained efficacy and safety of a new tramadol once-daily formulation (tramadol OAD) using Contramid ® controlled-release technology with a marketed twice-daily ...